Cutaneous T-cell lymphoma (CTCL), including mycosis fungoides (MF) and Sézary syndrome (SS), frequently presents with severe pruritus.1,2 Interleukin-31 (IL-31), a T helper type 2 cytokine, elevated in the serum and skin of patients with CTCL may be associated with pruritus.3,4 Nemolizumab, a monoclonal antibody targeting the IL-31 receptor alpha subunit, is approved for prurigo nodularis and atopic dermatitis and increasingly used off-label for CTCL-associated itch.5 Routine effectiveness...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Thomas
Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack